Get the Stockscreener App
8.53
23.77%
-2.66
Pre-market:
7.27
-1.26
-14.77%
Co Diagnostics Inc stock is traded at $8.53, with a volume of 3.33M.
It is down -23.77% in the last 24 hours and up +457.52% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$11.19
Open:
$11.31
24h Volume:
3.33M
Relative Volume:
0.55
Market Cap:
$31.20M
Revenue:
$418.20K
Net Income/Loss:
$-46.90M
P/E Ratio:
-0.3526
EPS:
-24.1892
Net Cash Flow:
$-29.84M
1W Performance:
+68.24%
1M Performance:
+457.52%
6M Performance:
-64.22%
1Y Performance:
-87.42%
1-Day Range:
$8.10
$13.53
1-Week Range:
$6.3311
$13.54
52-Week Range:
$1.26
$13.54
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 438-1036
Address
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
8.53 | 40.93M | 418.20K | -46.90M | -29.84M | -24.19 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Is Co-Diagnostics National Security's next diagnostic pick? - MSN
Co-Diagnostics develops Ebola assay strategy following WHO emergency alert (CODX) - MSN
$Co-diagnostics (CODX.US)$ Fuhh... - Moomoo
Co-Diagnostics (CODX) registers 4.94M shares for resale; up to $5.18M possible - Stock Titan
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
$Co-diagnostics (CODX.US)$ more the boyzzz want - Moomoo
$Astrotech (ASTC.US)$ $Qtrex Quantum (QTEX.US)$ $Co-diagnostics (CODX.US)$ - Moomoo
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Co-Diagnostics (CODX) Q4 2025 Earnings Transcript - AOL.com
Co-Diagnostics (NASDAQ: CODX) CEO nets RSU shares after tax sale - Stock Titan
Co-Diagnostics (NASDAQ: CODX) CFO reports RSU vesting and tax-related share sale - Stock Titan
Co-Diagnostics (NASDAQ: CODX) president nets RSU shares after tax sale - Stock Titan
Co-Diagnostics (CODX) director receives 1,695-share equity grant - Stock Titan
Director at Co-Diagnostics (NASDAQ: CODX) receives 1,695-share equity grant - Stock Titan
[Form 4] Co-Diagnostics, Inc. Insider Trading Activity - Stock Titan
Co-Diagnostics (NASDAQ: CODX) director awarded 1,695 shares and exercises RSUs - Stock Titan
$Co-diagnostics (CODX.US)$ - Moomoo
Co-Diagnostics (CODX) Enhances PCR Assay Development for Ebola O - GuruFocus
Co-Diagnostics Shares Surge as Investors React to Ebola-test Development Update and Outbreak Headlines - Moomoo
Co-Diagnostics shares surge as investors react to Ebola-test development update and outbreak headlines - Quiver Quantitative
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Yahoo Finance
Co-Diagnostics Advances Ebola Pcr Assay Development Strategy with Joint Venture Cosara - marketscreener.com
21.00 🙏 - Moomoo
CODX Stock Rockets As Saudi Facility And Ebola Assay Shift Outlook - StocksToTrade
Co-Diagnostics stock surges on Ebola test development plan By Investing.com - Investing.com Nigeria
Co-Diagnostics stock surges on Ebola test development plan - Investing.com
$Co-diagnostics (CODX.US)$ good runner! hope to play yoy again later :) - Moomoo
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara - Financial Times
CODX - Finviz
$Co-diagnostics (CODX.US)$ 🫡 - Moomoo
Point-Of-Care Virus Testing - Trend Hunter
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Co-Diagnostics Analyst Ratings and Price Targets | NASDAQ:CODX - Benzinga
Co-Diagnostics (CODX) Q1 2026 Earnings Transcript - AOL.com
Co-Diagnostics Develops Strategy for Ebola Bundibugyo Virus Assay - Clinical Lab Products
Co-Diagnostics (CODX) registers resale of 4.94M shares from May 2026 private placement - Stock Titan
CODX Stock Pops As Co-Diagnostics Targets MENA Growth - StocksToTrade
CODX Stock Jumps As Saudi Facility And Ebola Assay Fuel Momentum - timothysykes.com
Co-Diagnostics Announces $3 Million Private Placement Financing - TipRanks
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Co-Diagnostics Raises $3.0 Million in Private Placement; Investors Get Registration Rights; Maxim Engaged - TradingView
Co-Diagnostics (NASDAQ: CODX) prices $3M private placement with warrants - Stock Titan
What's going on with Co-Diagnostics stock Wednesday? - MSN
What's Going On With Co-Diagnostics Stock Wednesday? - Benzinga
Co-Diagnostics, Inc. Commemorates Third Anniversary of the Compl - GuruFocus
Co-Diagnostics jumps 11%, raises $3M privately - MSN
Co-Diagnostics Jumps; $3 Million Deal Looms - TechStock²
Co-Diagnostics (CODX) Secures $3M in Private Placement, Stock Su - GuruFocus
Co-Diagnostics announces $3 million private placement By Investing.com - Investing.com South Africa
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):